Sr.Rayala.Hypo Share Price ₹523 | P/E 9.1

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Sr.Rayala.Hypo

Quarter-by-quarter operating performance

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales +	301	435	261	226	215	165	169	170	138	160	180	182	141
Expenses +	274	371	226	199	192	138	142	140	117	143	152	155	121
Operating Profit	26	64	35	26	22	27	27	30	21	18	28	27	20
OPM %	9%	15%	13%	12%	10%	16%	16%	18%	15%	11%	16%	15%	14%
Other Income +	11	20	1	2	4	5	3	9	13	12	6	7	16
Interest	0	1	1	1	1	2	0	0	0	1	0	0	0
Depreciation	5	5	3	3	3	3	1	2	1	1	1	1	1
Profit before tax	32	79	33	25	23	27	28	36	32	28	32	32	35
Tax %	26%	9%	26%	27%	29%	23%	26%	29%	27%	19%	28%	24%	30%
Net Profit +	24	71	24	18	17	21	20	26	24	23	23	24	24
EPS in Rs	13.72	41.45	14.17	10.78	9.69	12.22	11.94	15.12	13.71	13.23	13.64	14.20	14.16

Financials of Sr.Rayala.Hypo

Annual income statement trend

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	295	392	362	366	546	702	689	911	1,267	1,650	866	638	664
Expenses +	262	351	318	317	500	604	587	781	1,119	1,470	755	542	570
Operating Profit	33	41	44	50	46	98	102	130	149	180	111	96	94
OPM %	11%	10%	12%	14%	8%	14%	15%	14%	12%	11%	13%	15%	14%
Other Income +	9	9	2	-2	19	5	4	7	11	34	13	36	41
Interest	16	14	11	8	9	16	10	5	3	5	4	2	2
Depreciation	15	10	10	25	19	45	50	51	19	19	11	6	6
Profit before tax	12	26	26	15	37	42	45	81	137	190	109	124	127
Tax %	36%	25%	27%	-27%	1%	52%	17%	25%	25%	19%	26%	25%
Net Profit +	7	19	19	18	37	20	38	61	103	154	80	93	95
EPS in Rs	5.06	13.16	12.72	11.86	22.45	11.90	22.09	35.30	59.88	89.90	46.85	53.99	55.23
Dividend Payout %	0%	11%	12%	13%	9%	17%	11%	8%	6%	4%	6%	6%

Financials of Sr.Rayala.Hypo

Capital structure and asset base

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	15	15	15	15	16	17	17	17	17	17	17	17	17
Reserves	135	157	173	222	302	308	294	371	553	734	785	905	993
Borrowings +	88	87	85	55	78	52	57	72	28	16	5	15	13
Other Liabilities +	130	99	84	60	64	93	76	59	189	174	100	121	133
Total Liabilities	367	358	357	352	460	470	445	519	787	941	907	1,059	1,156
Fixed Assets +	200	194	195	182	194	194	161	134	130	105	103	112	111
CWIP	0	5	2	8	0	0	3	0	0	0	0	0	0
Investments	32	23	23	43	105	65	18	50	164	268	253	366	407
Other Assets +	135	136	137	118	161	210	262	334	494	568	551	580	638
Total Assets	367	358	357	352	460	470	445	519	787	941	907	1,059	1,156

Financials of Sr.Rayala.Hypo

Operating, investing and financing cash movement

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	20	36	15	47	5	60	99	71	60	131	132	88
Cash from Investing Activity +	-9	-5	-3	-19	-27	-24	-38	-115	-1	-99	-8	-40
Cash from Financing Activity +	-9	-32	-12	-19	16	-37	-22	10	-52	-20	-22	-8
Net Cash Flow	2	-1	-0	8	-6	-1	40	-35	7	12	103	39
Free Cash Flow	12	14	8	28	-23	15	91	50	46	136	123	85
CFO/OP	73%	104%	49%	106%	2%	72%	108%	82%	62%	117%	145%	124%

Financials of Sr.Rayala.Hypo

Working capital efficiency and return ratios

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	33	33	54	30	38	46	43	39	38	33	45	59
Inventory Days	67	42	37	55	34	34	36	27	62	39	24	49
Days Payable	97	79	39	66	21	38	24	8	33	22	10	18
Cash Conversion Cycle	3	-4	51	19	51	41	55	57	67	50	59	90
Working Capital Days	-23	-15	1	12	16	32	24	23	47	45	67	79
ROCE %	11%	13%	14%	9%	9%	14%	15%	21%	26%	26%	16%	15%

Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

Sr.Rayala.Hypo Share Price & Earnings Call Analysis